CAPRI National Juvenile Idiopathic Arthritis Registry

NCT ID: NCT03245801

The CAPRI National Juvenile Idiopathic Arthritis (JIA) Registry is a research study that aims to gather important information about JIA, a condition that causes long-lasting inflammation in the joi...

Recruiting

Conditions: Juvenile Idiopathic Arthritis (JIA)

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

NCT ID: NCT03435796

This clinical trial is focused on following up with patients who have received a special treatment called gene-modified T cell therapy for cancer. The study aims to gather information about the lon...

Recruiting

Phase: PHASE2 Conditions: Neoplasms

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

NCT ID: NCT05196035

This clinical trial is investigating a new treatment called finerenone for children with chronic kidney disease (CKD) and proteinuria, which is when the kidneys leak too much protein into the urine...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease, Proteinuria

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

NCT ID: NCT05492578

This clinical trial is studying a treatment called amlitelimab for people aged 12 and older who have moderate to severe atopic dermatitis (a type of skin condition that causes itching and inflammat...

Recruiting

Phase: PHASE2 Conditions: Dermatitis Atopic

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

NCT ID: NCT05514054

This clinical trial is studying a new treatment called imlunestrant to see how well it works compared to standard hormone therapy for patients with early breast cancer. The patients being considere...

Recruiting

Phase: PHASE3 Conditions: Breast Neoplasms

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

NCT ID: NCT06091254

This clinical trial is studying a new experimental drug called odronextamab to see if it is safe and effective for people with follicular lymphoma, a type of blood cancer. The trial has two parts: ...

Recruiting

Phase: PHASE3 Conditions: Follicular Lymphoma (FL)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT ID: NCT06118281

The ARTEMIS clinical trial is investigating a new medication called ziltivekimab, which researchers hope can help people who have recently had a heart attack. The goal is to see if ziltivekimab can...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Risk, Acute Myocardial Infarction (AMI)

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

NCT ID: NCT06439277

This clinical trial, called SURMOUNT-ADOLESCENTS-2, is studying a medication called tirzepatide to see how it helps adolescents with obesity and related health issues, like high blood pressure or p...

Recruiting

Phase: PHASE3 Conditions: Obesity, Weight Gain

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

NCT ID: NCT06619509

This clinical trial is looking at how well adults with solid tumors can handle long-term treatment with a medication called brigimadlin. This study is specifically for individuals who have already ...

Recruiting

Phase: PHASE2 Conditions: Solid Tumours

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT ID: NCT06632444

The LIVERAGE™ clinical trial is studying a medication called survodutide to see if it can help adults with a liver disease known as Metabolic Dysfunction Associated Steatohepatitis (MASH) who also ...

Recruiting

Phase: PHASE3 Conditions: Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

NCT ID: NCT06632457

The LIVERAGE™ study is researching whether a medication called survodutide can help adults with a liver disease known as non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction Associated Steatohepatitis

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

NCT ID: NCT06962280

This clinical trial is studying a medication called tirzepatide, which is being tested for its effectiveness and safety in adults with type 1 diabetes who are also overweight or obese. The goal is ...

Recruiting

Phase: PHASE3 Conditions: Obesity, Overweight +1 more

Two Dose Levels of Privigen in Pediatric CIDP

NCT ID: NCT03684018

This clinical trial, titled “Two Dose Levels of Privigen in Pediatric CIDP,” is studying the effects of a medication called Privigen on children and teenagers aged 2 to 17 who have been diagnosed w...

Recruiting

Phase: PHASE4 Conditions: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT ID: NCT05006716

This clinical trial is studying a new treatment called BGB-16673 for patients with specific types of B-cell cancers, such as Marginal Zone Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leu...

Recruiting

Phase: PHASE1 Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma +7 more

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT ID: NCT05020236

The MagnetisMM-5 clinical trial is studying a new treatment option for people with relapsed or refractory multiple myeloma, a type of blood cancer. Researchers want to see if a medication called el...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

NCT ID: NCT05211895

This clinical trial is studying the effects of two medications, durvalumab and domvanalimab, on adults with Stage III non-small cell lung cancer (NSCLC) that cannot be surgically removed. The trial...

Recruiting

Phase: PHASE3 Conditions: Non-Small Cell Lung Cancer

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

NCT ID: NCT05911295

This clinical trial is studying two different treatment options for patients with urothelial cancer, which can affect the bladder, kidneys, or urinary tubes. The researchers want to find out if a c...

Recruiting

Phase: PHASE3 Conditions: Urothelial Carcinoma

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

NCT ID: NCT05939414

This clinical trial is studying a new treatment called lutetium (177Lu) vipivotide tetraxetan for men with oligometastatic prostate cancer (OMPC), which means their cancer has spread to a few place...

Recruiting

Phase: PHASE3 Conditions: Oligometastatic Prostate Cancer (OMPC)

Main Menu

Clinical Trials in Calgary, Alberta

576 Active Trials Found in Calgary

CAPRI National Juvenile Idiopathic Arthritis Registry

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

Two Dose Levels of Privigen in Pediatric CIDP

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.